Tag: neurodegenerative disease
-
Gnome Sciences Unveils Promising ALS Results From Cancer Drug Study
Groundbreaking ALS Findings from a Cancer Drug Study Gnome Sciences, a leader in molecular pathology and translational research, announced a significant advance in the fight against amyotrophic lateral sclerosis (ALS). In a newly published study, researchers revealed that a cancer drug—originally developed to target tumor growth—demonstrated measurable neuroprotective effects in ALS models. The findings, produced…
-
ALS Breakthrough: Cancer Drug Shows Promise, Gnome Sciences Reports
Gnome Sciences Announces Promising ALS Research Gnome Sciences, a leader in molecular pathology and translational research, has announced encouraging results from a newly published study investigating the potential of a cancer drug in treating amyotrophic lateral sclerosis (ALS). The announcement, made in Columbus, Ohio, underscores a growing interest in repurposing oncology therapies to address complex…
-
Gnome Sciences Announces Cancer Drug Shows Promise for ALS Therapy in New Study
Breakthrough in ALS Research: A Cancer Drug Shows Promise In a notable advance for neurodegenerative disease research, Gnome Sciences, a leader in molecular pathology and translational studies, reports that a cancer drug demonstrates promising effects in models of amyotrophic lateral sclerosis (ALS). The company announced the findings following a newly published study that suggests the…
-
Alzheimer’s Disease Hijacks Brain-Fat Communication and Metabolism
Overview: A new link between Alzheimer’s and metabolic health Alzheimer’s disease is widely known for its impact on memory and cognition, but a growing body of research is revealing deeper consequences for the body’s metabolic systems. A recent study from Houston Methodist highlights how Alzheimer’s disease may hijack the brain’s communication with fat tissue, a…
-
Personalized Pain Care Could Transform Life for Australians with Parkinson’s
Understanding the Hidden Burden: Pain in Parkinson’s Disease Parkinson’s disease is widely associated with tremors and mobility challenges, yet many Australians living with the condition also wrestle with persistent, non-motor pain. In a country where 1 in roughly 180 people are diagnosed with Parkinson’s, the burden of pain compounds already difficult days, impacting sleep, mood,…
-
Smoking Tied to Faster Huntington’s Decline: What Clinicians Need to Know
Overview: Smoking as a Modifiable Factor in Huntington’s Disease Huntington’s disease (HD) is a progressive, currently incurable neurodegenerative disorder. While genetics set the stage, modifiable environmental factors may influence when symptoms start and how quickly they advance. A recent analysis using Periodic Dataset 4 from Enroll-HD examined 2,438 individuals, including 799 presymptomatic carriers with four…
-
Smoking Tied to Faster Huntington’s Decline: Implications for Clinical Practice
Overview: Smoking as a Modifiable Factor in Huntington’s Disease Huntington’s disease (HD) is a progressive, incurable neurodegenerative disorder characterized by motor, cognitive, and behavioral decline. While genetics determine risk, researchers are increasingly focused on modifiable environmental factors that might influence when symptoms begin and how quickly they worsen. A recent analysis using Periodic Dataset 4…
-
NeurologyLive Brain Games: Exploring Duchenne Muscular Dystrophy Gene Therapy
Welcome to NeurologyLive® Brain Games NeurologyLive® Brain Games returns with a focused look at neurology science through a weekly, clinician-written quiz. While the collection spans dementia, epilepsy, migraine, movement disorders, and more, this week centers on the cutting-edge topic of Duchenne muscular dystrophy (DMD) gene therapy. Each installment challenges you with three questions that blend…
-
EPG5 Gene Errors Tied to Vici Syndrome and Parkinson’s
New Links Between EPG5 Mutations, Early Neurodevelopment, and Later Neurodegeneration A groundbreaking study connects errors in the EPG5 gene, already known for causing the rare neurodevelopmental disorder Vici syndrome, to later-age neurodegenerative conditions such as Parkinson’s disease and dementia. Published in the Annals of Neurology, the research consortium spanning King’s College London, University College London…
-
EPG5 gene errors link infant syndrome to Parkinson’s disease
EPG5 gene errors connect infant neurodevelopmental disorder to adult neurodegeneration A surprising thread is emerging from recent research: errors in the EPG5 gene, already known to cause the severe infant condition Vici syndrome, may also contribute to the development of Parkinson’s disease and related dementias in adolescence and adulthood. The large, international study, published in…